Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Paxmedica Inc
(NQ:
PXMD
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Paxmedica Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA
May 29, 2024
Via
Investor Brand Network
Study Discovers Elevated Risk of Toxicity Among Autistic Kids
May 24, 2024
Via
Investor Brand Network
PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis
May 24, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments
May 22, 2024
Via
Investor Brand Network
Researcher Wants to Untangle Environmental, Genetic Complexities of Autism
May 08, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Appeals NASDAQ Delisting Decision, Prepares for June FDA Meeting
May 15, 2024
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101
May 15, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
PXMD Stock Earnings: PaxMedica Misses EPS for Q1 2024
May 13, 2024
PXMD stock results show that PaxMedica missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
BioMedNewsBreaks — PaxMedica Inc. (PXMD) Continues Advancement of PAX-101 Regulatory Strategy
May 07, 2024
Via
Investor Brand Network
Exposures
Product Safety
PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy
May 07, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA
May 01, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Featured in Latest Bell2Bell Podcast Release
April 26, 2024
Via
Investor Brand Network
“Urgent Action: PaxMedica Inc. (NASDAQ: PXMD) Addresses Medical Crisis in Malawi”
April 24, 2024
Via
Investor Brand Network
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Completes Key Step in Preparation of PAX-101 for NDA Submission to FDA
April 24, 2024
Via
Investor Brand Network
Exposures
Product Safety
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Responds to Emergency Request for IV Suramin, Commits to Provide Immediate Access to PAX-101
April 23, 2024
Via
Investor Brand Network
PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
April 23, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
Misinformation on TikTok Causing Many to Misdiagnose Themselves as Autistic
April 19, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 19, 2024
Via
Benzinga
BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) in Process of Responding to Emergency Request for IV Suramin from African Health Ministry
April 17, 2024
Via
Investor Brand Network
Exposures
Product Safety
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 16, 2024
Via
Benzinga
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness
April 16, 2024
From
PaxMedica, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 16, 2024
Via
Benzinga
Dow Jumps Over 300 Points; Goldman Sachs Posts Upbeat Earnings
April 15, 2024
U.S. stocks traded higher this morning, with the Dow Jones index gaining more than 300 points on Monday. The Dow traded up 0.89% to 38,321.05 while the NASDAQ rose 0.70% to 16,288.03. The S&P 500 also...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 15, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 12, 2024
Via
Benzinga
Nasdaq Down 300 Points; BlackRock Posts Upbeat Earnings
April 12, 2024
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 500 points on Friday. The Dow traded down 1.37% to 37,934.02 while the NASDAQ fell 1.82% to 16,142.15. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 12, 2024
Shares of JPMorgan Chase & Co. (NYSE: JPM) fell sharply during Friday’s session following first-quarter earnings.
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 12, 2024
Via
Benzinga
Gold Jumps Over 2%; Wells Fargo Earnings Top Views
April 12, 2024
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% on Friday. The Dow traded down 0.82% to 38,143.73 while the NASDAQ fell 1.16% to 16,252.28. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Penny Stock PaxMedica's African Sleeping Sickness Candidate Moves Closer To FDA Marketing Application Submission, Stock Rallies
April 12, 2024
PaxMedica achieves pivotal milestone with completion of three registration/validation batches for PAX-101, an IV suramin formulation, advancing towards FDA submission in Q4 2024. Potential breakthrough...
Via
Benzinga
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.